Management is re-underwriting a specific asset or business at a value far above its cost, using fresh third-party marks
The model's full reasoning — Q4 2023 call → NOWe need to determine if management puts a concrete, externally-derived value on something the company already owns or controls, and conveys that this value is far above what the company paid, carries it at, or what current results imply. We need to look for a specific asset being valued with an outside reference point, and management conveying that the value is materially above cost/carrying value. In the transcript, management discusses various programs: dermal filler with AbbVie, breast implants, gut-on-a-chip, etc. They mention milestones, patents, market sizes. But do they put a concrete value on an asset they own? They mention that they have a patent, they have a product candidate, but they don't attach a specific dollar value to it based on an external reference. They talk about market sizes, but that's not valuing their specific asset. They also mention the collaboration with AbbVie, and that they received a $10 million milestone payment. But that's revenue, not a valuation of an asset they own. They also mention potential future milestones, but that's not a current valuation. They talk about the breast implant market size, but again, that's not valuing their specific implant. They mention the gut-on-a-chip program being put on hold, but no valuation. They mention ESG, but no. They mention cash runway, but that's not an asset valuation. They mention that they have a patent that strengthens their position, but no external value. They mention that they have a right of first negotiation for a product candidate, but no value. They mention that they have a collaboration with Stratasys, but no value. They mention that they have a product candidate that is in clinical phase, but no value. The question asks: "does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it at, or what the company's current results would imply?" Management does not seem to do that. They talk about potential market opportunities, but they don't say "this asset is worth X based on Y external evidence." They don't say "our rhCollagen technology is worth X because a comparable transaction happened." They don't cite an appraisal or a third-party offer.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TTI | TETRA Technologies, Inc. | Q1 2024 | 2024-05-01 | A |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
TTI · Q1 2024 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies a specific asset: its holdings in Standard Lithium and Kodiak Gas Services (marketable securities worth slightly over $13 million, with total marketable securities around $30 million). It grounds the value in an external reference—the recent Kodiak acquisition of CSI Compressco, which made the stake “very favorable to TETRA,” plus Kodiak’s $2.5 billion market cap and strong trading volumes that allow quick, low-pressure monetization.
GPRE · Q4 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Todd Becker explicitly identifies the company's ethanol plants as the specific asset being valued. He states that a high-quality plant trades in the private market at $1.80–$2.00 per gallon (or $2–$2.50 to build from scratch), while the company's overall market cap and net debt imply a lower value for its ~950 million gallon capacity.
AFL · Q2 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies the specific equity stake in Varagon Capital (a minority interest they already held) and grounds its value in the external transaction where Man Group is acquiring Varagon.